Press Releases
PhRMA Applauds Selection of Tom Daschle as HHS Secretary
Washington, D.C. (November 19, 2008) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today on Tom Daschle’s selection as incoming HHS Secretary:
“Tom Daschle is a wise choice to guide the President-elect on shaping healthcare reform. Sen. Daschle has what it takes to do the job: Smarts, toughness and a strong understanding of the healthcare challenges that face our nation in these tough economic times.
“As our nation’s leaders look ahead and begin to shape their agendas for next year, America’s pharmaceutical research and biotechnology companies – which lead the world in discovering new cures and treatments for patients – welcome the opportunity to help address the difficult healthcare challenges facing America.
“PhRMA is committed to working with lawmakers on both sides of the aisle and will continue to support policies that encourage and strengthen innovation, improve patient access to medicines and expand healthcare coverage for all Americans.”
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $44.5 billion in 2007 in discovering and developing new medicines. Industry-wide research and investment reached a record $58.8 billion in 2007.
PhRMA Internet Address: www.phrma.org
For information on stories of hope and survival, visit: http://sharingmiracles.com/
PhRMA en Español: www.nuestraphrma.org
For information on how innovative medicines save lives, visit: www.innovation.org
For information on the Partnership for Prescription Assistance, visit: www.pparx.org
For information on the danger of imported drugs, visit: www.buysafedrugs.info